| Literature DB >> 12668806 |
G Simpson1, D Roomes, B Reeves.
Abstract
Fibrinolytic enzymes, particularly streptokinase, are now widely used to treat empyema thoracis. Recent in vitro evidence suggests that streptokinase has no effect on pus viscosity but that deoxyribonuclease (DNase) reduces the viscosity of pus. We report the first use of human recombinant DNase given intrapleurally to treat an empyema which had not resolved after standard treatment with streptokinase.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12668806 PMCID: PMC1746626 DOI: 10.1136/thorax.58.4.365
Source DB: PubMed Journal: Thorax ISSN: 0040-6376 Impact factor: 9.139